Search Results for

NRG-BR007

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Continue Reading »

---

EA1181

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Continue Reading »

---

A191901

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

Continue Reading »

---

EAZ171

Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

Continue Reading »

---

MA.39

Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer (TAILOR RT)

Continue Reading »

---

AFT-25

Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS

Continue Reading »

---

URCC 16070

Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Continue Reading »

---

Search Again

• All Trial Categories Anal  (2) Bladder/Urinary Tract Cancer  (6)    Metastatic  (3)    Neoadjuvant  (2) Brain  (9)    Glioblastoma Multiforme (GBM)  (3)    Other Brain Tumors  (3) Breast  (7)    Breast Cancer Adjuvant  (2)    DCIS/LCIS  (1) Cancer Control/Symptom Management  (23) Carcinoid Tumors  (1) Colorectal Cancer  (8)    Metastatic  (2)    Rectal Neoadjuvant  (1) Esophageal Cancer  (1) Gall Bladder/ Biliary Tract Cancer  (1) Head/Neck Cancer  (6) Leukemia  (1)    Acute Myeloid Leukemia (AML)  (1) Liver/Hepatocellular Carcinoma  (1) Lung Cancer  (22)    Non-Small Cell Lung Cancer  (16)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (4)       2nd Line Metastatic, Stage 4 Patients with Progressive Disease  (3)       Adjuvant Treatment for Resected NSCLC  (4)    Small Cell Lung Cancer  (6)       Extensive Stage SCLC  (4) Lymphoma  (2)    Non-Hodgkin’s Lymphoma  (1) MDS  (1) Melanoma  (1) Merkel Cell Carcinoma  (1) Multiple Myeloma  (2) Ovarian  (1) Pancreatic  (5)    Metastatic Disease  (2) Prostate  (10) Renal Cell/Kidney Cancer  (3)    Locally Advanced/Metastatic  (3) Sarcoma  (2)